U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06416709) titled 'Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases' on May 11.

Brief Summary: The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for Lung injury caused by major infectious diseases.

Study Type: Interventional

Condition: Lung Injury

Intervention: * Drug: mesenchymal stem cells

Mesenchymal stem cell dose is 5x10*7/10ml and is transplanted by intravenous infusion. The cells are used once every three days and for three times

Other Name: KY-2023-2-6-2

* Other: saline

10 ml salin...